Cognitive Behavioral Therapy for Insomnia in Pain Management for Nonspecific Chronic Spinal Pain: A Randomized Clinical Trial

物理疗法 失眠症 医学 失眠的认知行为疗法 随机对照试验 认知疗法 认知行为疗法 多导睡眠图 心理干预 慢性疼痛 精神科 内科学 呼吸暂停
作者
Anneleen Malfliet,Liesbet De Baets,Thomas Bilterys,Eveline Van Looveren,Olivier Maîresse,Barbara J. Cagnie,Mira Meeus,Maarten Moens,Dorien Goubert,Wouter Munneke,Lieven A. Danneels,Kelly Ickmans,Steven James Kamper,Jo Nijs
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (8): e2425856-e2425856 被引量:29
标识
DOI:10.1001/jamanetworkopen.2024.25856
摘要

Importance: Insomnia is highly prevalent in patients with nonspecific chronic spinal pain (nCSP). Given the close interaction between insomnia and pain, targeting sleep problems during therapy could improve treatment outcomes. Objective: To evaluate the effectiveness of cognitive behavioral therapy for insomnia (CBTi) integrated in best-evidence pain management (BEPM) vs BEPM only in patients with nCSP and insomnia. Design, Setting, and Participants: A multicenter randomized clinical trial with 1-year follow-up was conducted between April 10, 2018, and April 30, 2022. Data and statistical analysis were performed between May 1, 2022, and April 24, 2023. Patients with nCSP and insomnia were evaluated using self-report and at-home polysomnography, to exclude underlying sleep pathologic factors. Participants were treated at the University Hospital Brussels or University Hospital Ghent, Belgium. Intention-to-treat analysis was performed. Interventions: Participants were randomized to either CBTi-BEPM or BEPM only. Both groups received 18 treatment sessions over 14 weeks. The CBTi-BEPM treatment included 6 CBTi sessions and 12 BEPM sessions. The BEPM treatment included pain neuroscience education (3 sessions) and exercise therapy (9 sessions in the CBTi-BEPM group, 15 sessions in the BEPM-only group). Main Outcomes and Measures: The primary outcome was change in mean pain intensity (assessed with Brief Pain Inventory [BPI]) at 12 months after the intervention. Exploratory secondary outcomes included several pain- and sleep-related outcomes. Blinded outcome assessment took place at baseline, posttreatment, and at 3-, 6-, and 12-month follow-up. Results: A total of 123 patients (mean [SD] age, 40.2 [11.18] years; 84 women [68.3%]) were included in the trial. In 99 participants (80.5%) with 12-month BPI data, the mean pain intensity at 12 months decreased by 1.976 points (reduction of 40%) in the CBTi-BEPM group and 1.006 points (reduction of 24%) points in the BEPM-only group. At 12 months, there was no significant difference in pain intensity change between groups (mean group difference, 0.970 points; 95% CI, -0.051 to 1.992; Cohen d, 2.665). Treatment with CBTi-BEPM resulted in a response for BPI average pain with a number needed to treat (NNT) of 4 observed during 12 months. On a preliminary basis, CBTi-BEPM was, consistently over time and analyses, more effective than BEPM only for improving insomnia severity (Cohen d, 4.319-8.961; NNT for response ranging from 2 to 4, and NNT for remission ranging from 5 to 12), sleep quality (Cohen d, 3.654-6.066), beliefs about sleep (Cohen d, 5.324-6.657), depressive symptoms (Cohen d, 2.935-3.361), and physical fatigue (Cohen d, 2.818-3.770). No serious adverse effects were reported. Conclusions and Relevance: In this randomized clinical trial, adding CBTi to BEPM did not further improve pain intensity reduction for patients with nCSP and comorbid insomnia more than BEPM alone. Yet, as CBTi-BEPM led to significant and clinically important changes in insomnia severity and sleep quality, CBTi integrated in BEPM should be considered in the treatment of patients with nCSP and comorbid insomnia. Further research can investigate the patient characteristics that moderate the response to CBTi-BEPM in terms of pain-related outcomes, as understanding of these moderators may be of utmost clinical importance. Trial Registration: Clinical Trials.gov Identifier: NCT03482856.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
摸鱼博士完成签到,获得积分10
2秒前
韭菜发布了新的文献求助10
2秒前
xiaozhulin完成签到,获得积分10
2秒前
华无剑的应助被elisa828采纳,获得10
2秒前
3秒前
moon发布了新的文献求助10
3秒前
左代灵完成签到,获得积分10
3秒前
还如一梦中完成签到,获得积分10
3秒前
tianyuer发布了新的文献求助30
3秒前
千春发布了新的文献求助20
4秒前
JamesPei的应助被wyn采纳,获得10
4秒前
Ali的应助被831143采纳,获得10
5秒前
XS完成签到,获得积分20
5秒前
5秒前
英俊的铭的应助被船c采纳,获得10
5秒前
高高的红牛完成签到,获得积分20
5秒前
6秒前
6秒前
6秒前
情怀的应助被博士僧采纳,获得10
7秒前
打打的应助被Log采纳,获得10
7秒前
7秒前
jmx234发布了新的文献求助10
8秒前
韭菜完成签到,获得积分10
8秒前
李健的小迷弟的应助被小剧场采纳,获得10
9秒前
迟暮完成签到 ,获得积分10
9秒前
我太帅了发布了新的文献求助50
9秒前
9秒前
10秒前
11秒前
12秒前
12秒前
欧耶耶完成签到 ,获得积分10
12秒前
12秒前
852的应助被Abandon1采纳,获得10
13秒前
13秒前
不灵0发布了新的文献求助10
14秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190724
求助须知:如何正确求助?哪些是违规求助? 9577784
关于积分的说明 21855018
捐赠科研通 7789883
什么是DOI,文献DOI怎么找? 3436455
关于科研通互助平台的介绍 2560308
邀请新用户注册赠送积分活动 2483172